ANDREWS DEBORAH J

Track

Insider profile

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 42% 68% 82%
Transactions
5 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
ANDREWS DEBORAH J's trades of Lineage Cell Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
446.99
Quantity 42,118 +30.9%
Value US$3,634,365
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2018-09-13 2018-09-11
B Purchase
95,979 +39.7%
241.52
US$187,966 		95,979 +39.7% 241.52 US$187,966
2017-08-23 2017-08-21
B Purchase
42,118 +30.9%
446.99
US$3,634,365 		42,118 +30.9% 446.99 US$3,634,365
2017-06-21 2017-06-16
B Purchase
510 -45.0%
145.43
US$2,786,034 		510 -45.0% 145.43 US$2,786,034
2017-05-17 2017-05-16
B Purchase
2,000 +100.0%
3.21
US$6,410 		2,000 +100.0% 3.21 US$6,410
2015-08-26 2015-08-26
B Purchase
2,000 +inf%
2.82
US$5,640 		2,000 +inf% 2.82 US$5,640